You just read:

Symbiomix Therapeutics Announces Positive Results from Phase 3 Trial of SYM-1219 for Bacterial Vaginosis, and Pre-NDA Meeting with FDA Supportive of 2016 NDA Filing

News provided by

Symbiomix Therapeutics, LLC

May 26, 2016, 08:30 ET